Webinar - Proposed Revision to EU GMP Annex 16 on Qualified Persons
PrintUpdate on the long awaited proposed revision to the EU GMP Annex 16 on Qualified Persons
Dates:
Monday 09 September 2025
Venue:
Webinar
Cost:
$99.00
Type: Pharmaceutical
Book now Print PDF
About this course
The draft revision of Annex 16 is a complete re-writing of this crucial guidance that addresses the fundamentals of how medicinal (drug) products are released for sale within the EU/EEA. This draft seeks to address the challenges posed by the continuing globalisation of pharmaceutical manufacturing and improve harmonisation across Europe.
In this webinar Peter Gough, NSF Health Sciences expert on pharmaceutical law and the role of the Qualified Person (QP), will review the proposed revision and look at the changes that this could make to areas such as:
- The responsibilities of MA holder and the QP
- The linkage between QP certification and batch release
- The process of QP certification
- The sampling and testing of imported products
- The use of third party audits
- Unplanned deviations and the so called ‘QP discretion’
Comments on the proposed changes are due by 7 November, so don’t miss this opportunity to fully understand the implications of this extensive change.